pentamidine has been researched along with amphotericin b in 157 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (4.46) | 18.7374 |
1990's | 25 (15.92) | 18.2507 |
2000's | 53 (33.76) | 29.6817 |
2010's | 63 (40.13) | 24.3611 |
2020's | 9 (5.73) | 2.80 |
Authors | Studies |
---|---|
Dunbar, DC; Ferreira, D; Jacob, MR; Li, XC; Muhammad, I; Tekwani, BL | 1 |
Hamann, MT; Mesecar, AD; Rao, KV; Santarsiero, BD; Schinazi, RF; Tekwani, BL | 1 |
Bedir, E; Dunbar, DC; Ferreira, D; Khan, SI; Muhammad, I; Takamatsu, S; Tekwani, BL; Walker, LA | 1 |
Avery, MA; Bandyopadhyaya, AK; Desai, PV; Furtado, MM; Muraleedharan, KM; Tekwani, BL | 1 |
Bedir, E; Khan, IA; Khan, SI; Muhammad, I; Pelletier, J; Takamatsu, S; Tekwani, BL; Walker, LA | 1 |
Hamann, MT; Kasanah, N; Rao, KV; Schinazi, RF; Tekwani, BL; Wahyuono, S | 1 |
Avery, M; Desai, PV; Gut, J; Patny, A; Rosenthal, P; Sabnis, Y; Srivastava, A; Tekwani, B | 1 |
Salem, MM; Werbovetz, KA | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Avery, M; Desai, PV; Gut, J; Patny, A; Rosenthal, PJ; Srivastava, A; Tekwani, B | 1 |
Ankisetty, S; ElSohly, HN; Khan, SI; Li, XC; Smillie, T; Tekwani, BL; Walker, L | 1 |
Jin, W; Zjawiony, JK | 1 |
Alonso, D; Donia, MS; Franzblau, SG; Garcia-Palomero, E; Hamann, MT; Khan, SI; Martinez, A; Medina, M; Peng, J; Rao, KV; Tekwani, BL; Wahyuono, S; Willett, KL | 1 |
Fan, X; Loiseau, PM; Torrence, PF; Zhang, X | 1 |
Bharate, SB; Chauthe, SK; Jacob, MR; Khan, IA; Khan, SI; Singh, IP; Tekwani, BL; Yunus, NA | 1 |
Jacob, MR; Jain, M; Jain, R; Kaur, K; Khan, SI; Patel, SR; Patil, P; Tekwani, BL | 1 |
Ablordeppey, SY; Fan, P; Jacob, M; Khan, A; Khan, S; Li, S; Mardenborough, LG; Walker, L; Zhang, W; Zhu, XY | 1 |
Goyal, N; Gupta, S; Pandey, S; Suryawanshi, SN | 1 |
Haynes, RK; Krishna, S; Meade, JC; Mishina, YV | 1 |
Borne, RF; Khan, MO; Levi, MS; Tekwani, BL; Wilson, NH | 1 |
Bharate, SB; Jacob, M; Khan, IA; Khan, SI; Singh, IP; Tekwani, BL | 1 |
del Olmo, E; Giménez, A; López-Pérez, JL; Rebollo, O; Ruiz, G; San Feliciano, A | 1 |
Banerjee, S; Dastidar, SG; Gupta, AD; Hazra, A; Mondal, NB; Paira, P; Palit, P | 1 |
Avery, MA; Ferreira, EI; Khan, SI; Rando, DG; Tekwani, BL | 1 |
Hamann, MT; Kasanah, N; Shilabin, AG; Tekwani, BL | 1 |
Choudhary, MI; Devkota, KP; Kisangau, DP; Lenta, BN; Naz, Q; Sewald, N; Wansi, JD | 1 |
Abbaskhan, A; Choudhary, MI; Jan, S; Musharraf, SG; Sattar, SA | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Delfín, DA; Morgan, RE; Werbovetz, KA; Zhu, X | 1 |
Alley, MC; ElSohly, MA; Feng, S; Galal, AM; Gul, W; Hollingshead, MG; Kaur, G; Ross, SA; Slade, D | 1 |
Ashfaq, MK; Jacob, MR; Joshi, VC; Khan, SI; Manly, SP; Muhammad, I; Samoylenko, V; Tekwani, BL; Walker, LA | 1 |
Ahmed, SA; Elsohly, MA; Khan, IA; Radwan, MM; Ross, SA; Slade, D | 1 |
Ahmed, SA; Elsohly, MA; Galal, AM; Gul, W; Jacob, MR; Khan, SI; Radwan, MM; Ross, SA; Slade, D; Tekwani, BL | 1 |
Bhandari, K; Gupta, S; Marrapu, VK; Srinivas, N; Srivastava, S; Verma, A | 1 |
Benicewicz, DB; Chen, PC; Gryder, B; Guerrant, W; Khan, SI; Oyelere, AK; Patil, V; Tekwani, BL | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Boykin, DW; Hall, JE; Kyle, DE; Liu, Q; Madhubala, R; Mandal, S; Munde, M; Pandharkar, T; Parman, T; Riccio, E; Srivastava, A; Stephens, CE; Sweat, JM; Tidwell, RR; Wang, MZ; Werbovetz, KA; Wilson, WD; Zhu, X | 1 |
Guerrant, W; Gurard-Levin, ZA; Khan, SI; Mrksich, M; Mwakwari, SC; Oyelere, AK; Patil, V; Tekwani, BL | 1 |
Baumann, K; Bischof, SK; Bringmann, G; Brun, R; Dreher, J; Gulder, T; Kaiser, M; Moll, H; Müller, S; Stich, A; Winter, C | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Jacob, MR; Jain, M; Jain, R; Kaur, K; Khan, SI; Singh, PP; Singh, S; Tekwani, BL | 2 |
Carvalho, L; Castanys, S; Gamarro, F; Manzano, JI; Pérez-Victoria, JM | 1 |
Azas, N; Bouhlel, A; Curti, C; Dumètre, A; Paloque, L; Vanelle, P; Verhaeghe, P | 1 |
Bello, ML; Castro, HC; Chiaradia, LD; Dias, LR; Mascarello, A; Nunes, RJ; Pacheco, LK; Rodrigues, CR; Steindel, M; Stumpf, TR; Yunes, RA | 1 |
Caminos, AP; Labadie, GR; Panozzo-Zenere, EA; Tekwani, BL; Wilkinson, SR | 1 |
Duke, SO; Ferreira, D; Jacob, M; Khan, SI; Kumarihamy, M; Nanayakkara, NP; Tekwani, BL | 1 |
Azas, N; Casanova, M; Castera-Ducros, C; Dumètre, A; Hutter, S; Kraiem-M'rabet, M; Laget, M; Mbatchi, L; Paloque, L; Rathelot, P; Rault, S; Remusat, V; Vanelle, P; Verhaeghe, P | 1 |
Chan, KF; Chan, TH; Chow, LM; Wong, IL | 1 |
Cutler, HG; Cutler, SJ; Dugan, FM; Gao, J; Hill, RA; Jacob, MR; Khan, SI; León, F; Lupien, S; Radwan, MM; Tekwani, BL; Wang, X | 1 |
Bharate, JB; Bharate, SB; Jacob, MR; Khan, IA; Khan, SI; Maity, S; Mudududdla, R; Sharma, PR; Singh, B; Tekwani, BL; Vishwakarma, RA; Yadav, RR | 1 |
Alves, KF; Costa, ÉD; de Almeida, L; Dias, DF; Doriguetto, AC; dos Santos, MH; Maciel-Rezende, CM; Marques, MJ; Pires, FR; Viegas, C | 1 |
Buisson, D; Fromentin, Y; Gaboriaud-Kolar, N; Grellier, P; Lallemand, MC; Lenta, BN; Loiseau, PM; Michel, S; Mouray, E; Wansi, JD | 1 |
Arafa, RK; Boykin, DW; Brun, R; Ismail, MA; Jones, SK; Pandharkar, T; Patrick, DA; Tidwell, RR; Wenzler, T; Werbovetz, KA; Zhu, X | 1 |
Azas, N; Cantelli, C; Casanova, M; Castera-Ducros, C; Cohen, A; Crozet, MD; Hutter, S; Laget, M; Paloque, L; Rathelot, P; Remusat, V; Tanguy, F; Vanelle, P; Verhaeghe, P | 1 |
Andrioli, WJ; Araújo, MJ; Bastos, JK; Bertucci, C; Cavalcanti, BC; Conti, R; Cruz, AK; de Moraes, MO; Manfrim, V; Nanayakkara, DN; Pessoa, C; Pupo, MT; Sabino, J; Tedesco, D; Toledo, JS; Zanasi, R | 1 |
Boykin, DW; Brun, R; Liu, ZY; Wenzler, T; Zhu, X | 1 |
Bharate, SB; Jain, SK; Khan, IA; Khan, SI; Manda, S; Mohammed, S; Tekwani, BL; Vishwakarma, RA | 1 |
Abdel-baky, AM; Bishay, DW; Cutler, SJ; Ibrahim, MA; Malak, LG; Moharram, AM; Ross, SA; Tekwani, B | 1 |
Jain, S; Kornacki, JR; Mrksich, M; Oyelere, AK; Patil, V; Sodji, Q; Tekwani, BL | 1 |
Bevilaqua, CM; Campello, CC; de Alencar Araripe Noronha Moura, A; de Andrade, HF; de Figuereido, JR; de Morais, SM; Lobo, CH; Rodrigues, AP; Rondon, FC; Sales, AD; Vila-Nova, NS; Wilson, ME | 1 |
Azas, N; Bouhlel, A; Cohen, A; Curti, C; Hutter, S; Primas, N; Remusat, V; Tabélé, C; Terme, T; Vanelle, P | 1 |
Azas, N; Castera-Ducros, C; Cohen, A; Hutter, S; Kieffer, C; Laget, M; M'Rabet, MK; Rathelot, P; Rault, S; Remusat, V; Vanelle, P; Verhaeghe, P | 1 |
Chabot, GG; Deguin, B; Dumontet, V; Espindola, LS; Grellier, P; Grougnet, R; Mai, LH; Michel, S; Poulain, C; Quentin, L; Vo, HT | 1 |
Azas, N; Castera-Ducros, C; Cohen, A; Hutter, S; Kieffer, C; Laget, M; Paloque, L; Rathelot, P; Rault, S; Valentin, A; Vanelle, P; Verhaeghe, P | 1 |
Bolzani, Vda S; de Almeida, L; dos Santos, MB; Dutra, LA; Graminha, MA; Michels, PA; Passalacqua, TG; Regasini, LO; Torres, FA; Velásquez, AM; Yamasaki, PR | 1 |
Alves, RB; de Camargos, LF; de Souza Judice, WA; Espuri, PF; Freitas, RP; Gontijo, VS; Marques, MJ; Santos, FV | 1 |
Bowlin, TL; Ding, X; Kwasny, SM; Nguyen, ST; Opperman, TJ; Peet, NP; Williams, JD | 1 |
Ambrósio, SR; Mizuno, CS; Souza, AB; Tekwani, BL; Veneziani, RC | 1 |
Bosc, D; Cojean, S; Dubois, J; Franco, CH; Freitas-Junior, LH; Grellier, P; Loiseau, PM; Moraes, CB; Mouray, E | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Capaci, GR; Cardoso, VS; Mazotto, AM; Rodrigues, IA; Supuran, CT; Vermelho, AB | 1 |
Jäger, SN; Labadie, GR; Lepesheva, GI; Nocito, I; Porta, EOJ; Serra, EC; Tekwani, BL | 1 |
Carvalho, P; Cutler, SJ; Dale, OR; Elokely, KM; ElSohly, MA; Galal Osman, A; Gul, W; Husni, AS; Khan, S; Klein, ML; Radwan, M; Ross, SA; Slade, D; Yadav, VK | 1 |
Bergmann, BR; Borsodi, MPG; da Silva, AM; Ferreira, RS; Gazolla, PAR; Lima, WP; Teixeira, RR; Vasconcelos, GA; Vaz, BG | 1 |
Alcantara, LM; Cordeiro-da-Silva, A; Costantino, L; Costi, MP; Ellinger, B; Ferrari, S; Franco, CH; Freitas-Junior, LH; Gul, S; Kuzikov, M; Linciano, P; Luciani, R; Macedo, S; Moraes, CB; Pascoalino, B; Quotadamo, A; Santarem, N; Witt, G | 1 |
Cantizani, J; Cogo, J; Corrêa, AG; Cotillo, I; Filho, BPD; Martín, JJ; Nakamura, CV; Sangi, DP; Ueda-Nakamura, T | 1 |
Arshad, N; Ashraf, T; Aslam, J; Hamid, SZ; Hashim, J; Iqbal, T; Javed, S; Minhas, MA | 1 |
Doerksen, RJ; Ferreira, D; Ibrahim, MA; Malak, LG; Moharram, AM; Pandey, P; Ross, SA; Tekwani, B | 1 |
Azas, N; Basmaciyan, L; Belle Mbou, V; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, É; Casanova, M; Castera-Ducros, C; Cohen, A; Courtioux, B; Fairlamb, AH; Fersing, C; Hutter, S; Laget, M; Milne, R; Pedron, J; Piednoel, M; Primas, N; Rathelot, P; Since, M; Sournia-Saquet, A; Valentin, A; Vanelle, P; Verhaeghe, P; Wyllie, S | 1 |
Baptista, C; Bonucci, A; Cordeiro-da-Silva, A; Costantino, L; Costi, MP; di Pisa, F; Ellinger, B; Ferrari, S; Franco, C; Gul, S; Iacono, LD; Kuzikov, M; Landi, G; Linciano, P; Luciani, R; Mangani, S; Moraes, CB; Müller, W; Pöhner, I; Pozzi, C; Quotadamo, A; Santarem, N; Sesenna, A; Witt, G; Wittig, U | 1 |
Assis, RP; Baviera, AM; da Costa Clementino, L; da Silva, GVJ; do Espírito Santo, RD; Dos Santos, FN; Éberlin, MN; González, ERP; Graminha, MAS; Kalaba, P; Lubec, G; Passianoto, LVG; Sepulveda, AAL; Velásquez, ÁMA; Zehl, M | 1 |
Abdelhameed, A; Guo, P; Joice, AC; Li, J; Liao, X; McElroy, CA; Rakotondraibe, L; Slebodnick, C; Werbovetz, KA; Wilson, WD | 1 |
La-Venia, A; Labadie, GR; Medrán, NS; Pereira, CA; Sayé, M; Tekwani, BL | 1 |
Belardinelli, JM; Bortolotti, A; Fernández de Luco, J; Ghiano, DG; Hoffmann, P; Labadie, GR; Lherbet, C; Liu, N; Morbidoni, HR; Recio-Balsells, AI; Tekwani, B; Tonge, PJ | 1 |
Bhatia, R; Gupta, O; Monga, V; Pradhan, T | 1 |
Bryceson, A | 1 |
Biswas, UK; Jha, DN; Khan, AB; Mishra, M | 1 |
Bhaduri, A; Mukherjee, T; Patra, P; Sarkar, S | 1 |
Casillas, A; Costa, JR; de Dios Garcia, J; del Mar Sanz, M; Guijarro, C; Martinez, R; Rubio, R | 1 |
Feddersen, A; Sack, K | 1 |
Gil, A; Lavilla, P; López Dupla, JM; Pintado, V; Valencia, ME | 1 |
Lucey, CR; Lucey, DR | 1 |
Antoniskis, D; Larsen, RA | 1 |
Berman, JD; Gallalee, JV | 1 |
Bartlett, MS; Eichholtz, R; Smith, JW | 1 |
Berman, JD; Wyler, DJ | 1 |
Berman, JD | 1 |
Berman, JD; Langreth, SG; Lee, LS; Riordan, GP | 1 |
Kornblut, AD | 1 |
Bodley, AL; McGarry, MW; Shapiro, TA | 1 |
Bories, C; Boulard, Y; Deniau, M; Durand, R; Fusai, T; Houin, R; Paul, M; Rivollet, D | 1 |
Buffet, P; Caumes, E; Gentilini, M | 1 |
Alcácer, F; Aznar, J; Colomina, J; Ferriols, F; Magraner, J; Orovitg, F; Rodilla, F | 1 |
Bichile, LS | 1 |
Giri, OP | 1 |
Chandra, J; Patwari, AK | 1 |
Kovacs, JA; Martinez, A | 1 |
Fichtl, RE; Hariprashad, J; Murray, HW | 1 |
Mishra, M | 1 |
Schuster, FL; Visvesvara, GS | 1 |
Abril, V; Herrera, A; Ortega, E; Pedro, F; Sabater, V; Segarra, P | 1 |
Jha, BB | 1 |
Azas, N; Delmas, F; Di Giorgio, C; Gasquet, M; Timon-David, P | 1 |
Asari, S; Endo, T; Shimomura, Y; Tahara, K; Yanagihara, T | 1 |
Adrados, M; Alvar, J; González-Lahoz, JM; Jiménez, MI; Laguna, F; Martínez, ML; Martínez, P; Moreno, V; Polo, R; Soriano, V; Valencia, ME; Verdejo, J | 1 |
Craciunescu, DG; Loiseau, PM; Mbongo, N; Robert-Gero, M | 1 |
Holzmuller, P; Lemesre, JL; Sereno, D | 1 |
Dwivedi, SN; Kumar, J; Singh, R | 1 |
Sundar, S | 2 |
Afeltra, J; Dannaoui, E; Meis, JF; Rodriguez-Tudela, JL; Verweij, PE | 1 |
Ali, A | 1 |
Berman, J | 1 |
Booton, GC; Dunnebacke, TH; Schuster, FL; Yagi, S | 1 |
Singh, S; Sivakumar, R | 1 |
Kumar, A; Sundar, S | 1 |
Cortes, M; Cuellar, MA; Domard, M; Pétavy, AF; Prieto, Y; Sarciron, ME; Tapia, RA; Terreux, R; Walchshofer, N | 1 |
Bandyopadhyay, S; Chatterjee, M; Ganguly, S; Sarkar, A | 1 |
Chatterjee, M; Sundar, S | 1 |
Szegedi, J | 1 |
Minodier, P; Parola, P | 1 |
Aguado, JM; Costa, JR; López-Medrano, F; Rodriguez-Peralto, JL | 1 |
Amato, VS; Neto, VA; Nicodemo, AC; Siqueira, AM; Tuon, FF | 1 |
Amato, VS; Bacha, HA; Neto, VA; Nicodemo, AC; Tuon, FF | 1 |
Calza, L; Manfredi, R; Marinacci, G; Passarini, B | 1 |
Genovese, G; Hamann, MT; Morabito, M; Tedone, L | 1 |
Ait-Oudhia, K; Garcia, D; Gazanion, E; Ouaissi, A; Oury, B; Sereno, D; Seveno, M; Vergnes, B | 1 |
Andrade, CA; Martins, MM; Marzochi, MC; Oliveira, LF; Oliveira, RV; Passos, SL; Schubach, AO | 1 |
Balharbi, F; Banerjee, PS; Deborggraeve, S; Garg, R; Goel, M; Kumar, N; Lejon, V; Manchanda, S; Puliyel, J; Sharma, A; Singh Rana, UV; Singh, BP; Verma, A | 1 |
Reimão, JQ; Tempone, AG | 1 |
Azas, N; Dumètre, A; Gellis, A; Hutter, S; Lanzada, G; Ollivier, E; Vanelle, P | 1 |
Kumar, M; Singh, N; Singh, RK | 1 |
Barrett, MP; Croft, SL | 1 |
Cesetti, MV; de Morais, OO; Gomes, CM; Mendes, MS; Roselino, AM; Sampaio, RN | 1 |
Chegaev, K; Chin, CM; de Almeida, L; dos Santos, JL; Dutra, LA; Fruttero, R; Graminha, MA; Guglielmo, S; Martinez, I; Passalacqua, TG; Peccinini, RG; Reis, JS; Torres, FA | 1 |
Fox-Lewis, A; Lockwood, DNJ | 1 |
de Paula, E; Giorgio, S; Ortega, V | 1 |
Akpunarlieva, S; Barrett, M; Burchmore, R; Nayak, A | 1 |
Khan, IA; Khan, SI; Mahajan, S; Singh, IP; Tekwani, BL | 1 |
Amato, VS; Cieslinski, J; de Souza, RM; Imamura, R; Santos, CR; Tuon, FF | 1 |
Cunha, MAD; Luz, KG; Shaw, JJ; Sousa, ASV; Vechi, HT | 1 |
da Silva, JHM; de Barros, NB; de Figueiredo Nicolete, LD; Dos Santos Ferreira, A; Macedo, SRA; Nicolete, R; Valentim-Silva, JR | 1 |
Bartoloni, A; Basile, G; Bresci, S; Cristofaro, G; Di Muccio, T; Gaiera, G; Gallo, O; Gradoni, L; Gramiccia, M; Locatello, LG; Maggiore, G; Novelli, A; Piccica, M; Vellere, I; Zammarchi, L | 1 |
Beijnen, JH; Dorlo, TPC; Roseboom, IC; Rosing, H | 1 |
Al Fatease, A; Almari, AH; Alqahtani, T; Anjum, A; Bashir, S; Din, FU; Khan, GM; Maryiam, A; Moneeb Khan, M; Shabbir, K; Shafique, S; Zaidi, SS | 1 |
22 review(s) available for pentamidine and amphotericin b
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets.
Topics: Animals; Antiprotozoal Agents; Carbonic Anhydrases; Leishmania; Trypanosoma cruzi | 2017 |
Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships.
Topics: Animals; Cell Line, Tumor; Heterocyclic Compounds; Humans; Leishmania; Leishmaniasis; Molecular Structure; Small Molecule Libraries; Structure-Activity Relationship; Trypanocidal Agents | 2021 |
[Drug surveillance for adverse reactions in patients with human immunodeficiency virus infection].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Ganciclovir; HIV Infections; Humans; Opportunistic Infections; Pentamidine; Product Surveillance, Postmarketing; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1990 |
[Importance of drug carriers in the treatment of visceral leishmaniasis].
Topics: Amphotericin B; Drug Carriers; Drug Resistance; Humans; Leishmaniasis, Visceral; Liposomes; Pentamidine | 1995 |
[Treatment of localized cutaneous leishmaniasis].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1994 |
Anti leishmanial therapy--the changing scene.
Topics: Allopurinol; Amphotericin B; Antimony Sodium Gluconate; Humans; Leishmaniasis, Visceral; Pentamidine | 1994 |
Diagnosis and treatment of kala-azar.
Topics: Allopurinol; Amphotericin B; Antimony Sodium Gluconate; Child; Combined Modality Therapy; Humans; Ketoconazole; Leishmaniasis, Visceral; Pentamidine; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity; Splenectomy | 1994 |
Treatment of visceral leishmaniasis.
Topics: Administration, Oral; Amphotericin B; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Paromomycin; Pentamidine | 2001 |
Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Bone Marrow Examination; Drug Administration Schedule; Endemic Diseases; Humans; Leishmaniasis; Morbidity; Patient Selection; Pentamidine; Public Health; Time Factors | 2002 |
Current treatment approaches to leishmaniasis.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Fluconazole; Humans; Leishmaniasis; Paromomycin; Pentamidine; Phosphorylcholine | 2003 |
Challenges and new discoveries in the treatment of leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmania; Leishmaniasis; Pentamidine; Phosphorylcholine; Psychodidae | 2004 |
Visceral leishmaniasis - current therapeutic modalities.
Topics: Administration, Oral; Amphotericin B; Animals; Antimony Sodium Gluconate; Antineoplastic Agents; Antiprotozoal Agents; Humans; Immunologic Factors; Leishmania; Leishmaniasis, Visceral; Pentamidine | 2006 |
[Renal insufficiency caused by medicines, diagnostic processes, toxins].
Topics: Acetaminophen; Acute Kidney Injury; Aminoglycosides; Amphotericin B; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Cisplatin; Contrast Media; Cyclosporine; Foscarnet; Humans; Hungary; Ischemia; Kidney; Kidney Function Tests; Pentamidine; Prognosis | 2007 |
Cutaneous leishmaniasis treatment.
Topics: Administration, Cutaneous; Administration, Oral; Aminoquinolines; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Humans; Imiquimod; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis, Cutaneous; Paromomycin; Pentamidine; Phosphorylcholine | 2007 |
Treatment of mucosal leishmaniasis in Latin America: systematic review.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Latin America; Leishmania; Leishmaniasis, Mucocutaneous; Meglumine; Paromomycin; Pentamidine | 2007 |
Mucosal leishmaniasis . Current scenario and prospects for treatment.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Deoxycholic Acid; Developed Countries; Developing Countries; Drug Combinations; Endemic Diseases; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Pentamidine; Travel | 2008 |
Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Incidence; Leishmaniasis, Cutaneous; Pentamidine | 2011 |
Leishmaniasis: current status of available drugs and new potential drug targets.
Topics: Aminoquinolines; Amphotericin B; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Caspase Inhibitors; Cyclin-Dependent Kinases; Drug Discovery; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Leishmaniasis; Macrophages; Microbodies; Mitogen-Activated Protein Kinase Kinases; Paromomycin; Pentamidine; Phosphorylcholine; Polyamines; Protease Inhibitors; Sterols; Sulfhydryl Compounds; Topoisomerase Inhibitors | 2012 |
Management of trypanosomiasis and leishmaniasis.
Topics: Administration, Oral; Africa; Amphotericin B; Antiprotozoal Agents; Benzamides; Boron Compounds; Chagas Disease; Drug Therapy, Combination; Humans; India; Leishmaniasis; Nitroimidazoles; Pentamidine; Triazoles; Trypanosomiasis, African | 2012 |
Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Leishmaniasis; Liposomes; Nanoparticles; Paromomycin; Particle Size; Pentamidine; Phosphorylcholine; Surface Properties | 2017 |
Bioanalytical methods for pharmacokinetic studies of antileishmanial drugs.
Topics: Amphotericin B; Antiprotozoal Agents; Humans; Leishmaniasis; Pentamidine | 2023 |
2 trial(s) available for pentamidine and amphotericin b
Article | Year |
---|---|
Amphotericin versus pentamidine in antimony-unresponsive kala-azar.
Topics: Adult; Amphotericin B; Antimony Sodium Gluconate; Female; Humans; Leishmaniasis, Visceral; Male; Pentamidine; Prospective Studies | 1992 |
Treatment of visceral Leishmaniasis unresponsive to pentamidine with amphotericin B.
Topics: Adolescent; Adult; Amphotericin B; Drug Resistance; Female; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Pentamidine | 1994 |
133 other study(ies) available for pentamidine and amphotericin b
Article | Year |
---|---|
Antimicrobial and antiparasitic (+)-trans-hexahydrodibenzopyrans and analogues from Machaerium multiflorum.
Topics: Animals; Anti-Infective Agents; Antimalarials; Antiparasitic Agents; Benzopyrans; Candida albicans; Fabaceae; Inhibitory Concentration 50; Leishmania donovani; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peru; Plant Bark; Plants, Medicinal; Plasmodium falciparum; Staphylococcus aureus; Stereoisomerism | 2003 |
New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge.
Topics: Alkaloids; Animals; Anti-HIV Agents; Antiprotozoal Agents; Carbazoles; Carbolines; Crystallography, X-Ray; Indoles; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Nucleosides; Porifera; Pyrroles; Stereoisomerism | 2003 |
Antiparasitic alkaloids from Psychotria klugii.
Topics: Alkaloids; Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Leishmania donovani; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peru; Plants, Medicinal; Plasmodium falciparum; Psychotria; Quinazolines; Tumor Cells, Cultured | 2003 |
Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Artemisinins; Clone Cells; Drug Design; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Leishmania donovani; Malaria, Falciparum; Models, Molecular; Molecular Conformation; Plasmodium falciparum; Sesquiterpenes; Static Electricity; Stereoisomerism; Structure-Activity Relationship | 2003 |
A new antimalarial quassinoid from Simaba orinocensis.
Topics: Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Molecular Structure; Peru; Plants, Medicinal; Plasmodium falciparum; Quassins; Simaroubaceae; Tumor Cells, Cultured | 2004 |
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases.
Topics: Alkaloids; Animals; Anti-HIV Agents; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Carbolines; Indonesia; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Porifera | 2004 |
Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database.
Topics: Animals; Antimalarials; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Databases, Factual; Leishmania donovani; Models, Molecular; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Trypanocidal Agents | 2004 |
Antiprotozoal compounds from Psorothamnus polydenius.
Topics: Animals; Antiprotozoal Agents; Chlorocebus aethiops; Fabaceae; Inhibitory Concentration 50; Leishmania donovani; Macrophages; Plants, Medicinal; Trypanosoma brucei brucei; Vero Cells | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.
Topics: Animals; Antimalarials; Antiparasitic Agents; Binding Sites; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Databases, Factual; Leishmania donovani; Models, Molecular; Plasmodium falciparum; Quantitative Structure-Activity Relationship | 2006 |
Aromatic constituents of Uvaria grandiflora.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Inhibitory Concentration 50; Leishmania; New Guinea; Oxepins; Pentamidine; Plant Bark; Plants, Medicinal; Uvaria | 2006 |
5-alkylresorcinols from Merulius incarnatus.
Topics: Agaricales; Animals; Anti-Infective Agents; Candida albicans; Chlorocebus aethiops; Inhibitory Concentration 50; Leishmania; Methicillin Resistance; Microbial Sensitivity Tests; Resorcinols; Staphylococcus aureus; Stereoisomerism; Vero Cells | 2006 |
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.
Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oryzias; Plasmodium falciparum; Porifera; Structure-Activity Relationship | 2006 |
Structurally diverse 5-substituted pyrimidine nucleosides as inhibitors of Leishmania donovani promastigotes in vitro.
Topics: Animals; Antiprotozoal Agents; Inhibitory Concentration 50; Leishmania donovani; Pyrimidine Nucleosides; Structure-Activity Relationship | 2006 |
Antiprotozoal and antimicrobial activities of O-alkylated and formylated acylphloroglucinols.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; Candida albicans; Cell Proliferation; Cell Survival; Chlorocebus aethiops; Cryptococcus neoformans; Epithelial Cells; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Phloroglucinol; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vero Cells | 2007 |
Synthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and methemoglobin (MetHB) formation activities of new 8-quinolinamines.
Topics: Aminoquinolines; Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiparasitic Agents; Bacteria; Chlorocebus aethiops; Erythrocytes; Fungi; Humans; Indicators and Reagents; L-Lactate Dehydrogenase; Leishmania donovani; Magnetic Resonance Spectroscopy; Methemoglobin; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Vero Cells | 2007 |
Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents.
Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiparasitic Agents; Bacteria; Cell Line; Cell Survival; Chemical Phenomena; Chemistry, Physical; Chlorocebus aethiops; Fungi; Humans; Indicators and Reagents; Indole Alkaloids; Indoles; Isomerism; Leishmania donovani; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship; Vero Cells | 2007 |
Chemotherapy of leishmaniasis. Part V: Synthesis and in vitro bioevaluation of novel pyridinone derivatives.
Topics: Antiprotozoal Agents; Drug Evaluation, Preclinical; Humans; Leishmaniasis; Pyridones | 2007 |
Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth.
Topics: Animals; Anti-Infective Agents; Artemisinins; Calcium-Transporting ATPases; Parasitic Sensitivity Tests; Sesquiterpenes; Trypanosoma brucei rhodesiense; Trypanosoma cruzi | 2007 |
Synthesis of isoquinuclidine analogs of chloroquine: antimalarial and antileishmanial activity.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Chloroquine; Leishmania; Plasmodium falciparum; Quinuclidines | 2007 |
S-Euglobals: biomimetic synthesis, antileishmanial, antimalarial, and antimicrobial activities.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Biomimetic Materials; Leishmania donovani; Magnetic Resonance Spectroscopy; Molecular Structure; Mycobacterium avium Complex; Phloroglucinol; Plasmodium falciparum; Staphylococcus aureus; Structure-Activity Relationship; Terpenes | 2008 |
Leishmanicidal and trypanocidal activities of 2-aminocyclohexanol and 1,2-cyclohexanediamine derivatives.
Topics: Animals; Cyclohexanes; Cyclohexanols; Diamines; Inhibitory Concentration 50; Leishmania; Sphingosine; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2008 |
Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Catalysis; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Quinolines; Structure-Activity Relationship | 2009 |
Antileishmanial activity screening of 5-nitro-2-heterocyclic benzylidene hydrazides.
Topics: Animals; Free Radicals; Heterocyclic Compounds; Inhibitory Concentration 50; Leishmania donovani; Nitrofurans; Structure-Activity Relationship; Thiophenes; Trypanocidal Agents | 2008 |
Kinetic studies and bioactivity of potential manzamine prodrugs.
Topics: Administration, Oral; Animals; Antimalarials; Candida albicans; Carbolines; Chlorocebus aethiops; Cryptococcus neoformans; Disease Models, Animal; Inhibitory Concentration 50; Leishmania donovani; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Prodrugs; Vero Cells | 2008 |
Bioactive 5alpha-pregnane-type steroidal alkaloids from Sarcococca hookeriana.
Topics: Alkaloids; Anti-Bacterial Agents; Antiprotozoal Agents; Buxaceae; Cholinesterase Inhibitors; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Pregnanes; Spectrometry, Mass, Electrospray Ionization | 2008 |
Cycloartane triterpenoids from Astragalus bicuspis.
Topics: Animals; Antiprotozoal Agents; Astragalus Plant; Glycosides; Inhibitory Concentration 50; Leishmania major; Mice; Molecular Structure; NIH 3T3 Cells; Pakistan; Triterpenes | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Redox-active dinitrodiphenylthioethers against Leishmania: synthesis, structure-activity relationships and mechanism of action studies.
Topics: Animals; Antiprotozoal Agents; Chlorocebus aethiops; Leishmania donovani; Macrophages, Peritoneal; Membrane Potential, Mitochondrial; Mice; Mice, Inbred Strains; Oxidation-Reduction; Quantitative Structure-Activity Relationship; Reactive Oxygen Species; Sulfides; Vero Cells | 2009 |
Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity.
Topics: Angiogenesis Inhibitors; Animals; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Artemisinins; Cell Line, Tumor; Dimerization; Drug Screening Assays, Antitumor; Humans; Leishmania; Mice; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2009 |
Indolizidine, antiinfective and antiparasitic compounds from Prosopis glandulosa var. glandulosa.
Topics: Animals; Anti-Infective Agents; Antiparasitic Agents; Aspergillus fumigatus; Brain; Candida albicans; Chloroquine; Cryptococcus neoformans; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Indolizidines; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Nevada; Plants, Medicinal; Plasmodium berghei; Prosopis | 2009 |
Biologically active cannabinoids from high-potency Cannabis sativa.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Aspergillus fumigatus; Candida; Cannabinoids; Cannabis; Chlorocebus aethiops; Escherichia coli; Gas Chromatography-Mass Spectrometry; Leishmania donovani; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Plasmodium falciparum; Pseudomonas aeruginosa | 2009 |
Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.
Topics: Acetals; Antifungal Agents; Antineoplastic Agents; Antiprotozoal Agents; Artemisinins; Cell Line, Tumor; Cryptococcus neoformans; Dimerization; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization | 2009 |
Synthesis of substituted aryloxy alkyl and aryloxy aryl alkyl imidazoles as antileishmanial agents.
Topics: Antigens, Protozoan; Antigens, Surface; Antiprotozoal Agents; Cyclohexanes; Imidazoles; Leishmania donovani; Membrane Proteins; Neuraminidase; Protozoan Proteins; Structure-Activity Relationship | 2010 |
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.
Topics: Antimalarials; Antiprotozoal Agents; Histone Deacetylase Inhibitors; Histone Deacetylases; Leishmania donovani; Leishmaniasis; Malaria; Plasmodium falciparum; Structure-Activity Relationship; Triazoles | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Novel arylimidamides for treatment of visceral leishmaniasis.
Topics: Amidines; Animals; Antiprotozoal Agents; Biological Availability; Cricetinae; Disease Models, Animal; Drug Discovery; Female; Furans; Humans; In Vitro Techniques; Leishmania donovani; Leishmania major; Leishmania mexicana; Leishmaniasis, Visceral; Liver; Mesocricetus; Mice; Mice, Inbred BALB C; Microsomes, Liver; Mutagenicity Tests; Parasitemia; Parasitic Sensitivity Tests; Spleen; Tissue Distribution | 2010 |
Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton.
Topics: Antimalarials; Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Isoenzymes; Ketolides; Leishmania donovani; Models, Molecular; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Trypanocidal Agents | 2010 |
QSAR guided synthesis of simplified antiplasmodial analogs of naphthylisoquinoline alkaloids.
Topics: Alkaloids; Animals; Antimalarials; Isoquinolines; Magnetic Resonance Spectroscopy; Models, Molecular; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Synthesis, antiprotozoal, antimicrobial, β-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines).
Topics: Aminoquinolines; Animals; Anti-Infective Agents; Antiprotozoal Agents; Hemeproteins; Humans; Methemoglobin | 2011 |
Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major.
Topics: Adenosine Triphosphate; Aminoquinolines; Antiprotozoal Agents; Drug Resistance; Glycolysis; Leishmania major; Pyruvate Kinase | 2011 |
Synthesis and evaluation of monoamidoxime derivatives: toward new antileishmanial compounds.
Topics: Acetates; Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Inhibitory Concentration 50; Leishmania donovani; Life Cycle Stages; Macrophages; Mice; Microwaves; Organometallic Compounds; Oximes; Pentamidine; Structure-Activity Relationship | 2011 |
Trimethoxy-chalcone derivatives inhibit growth of Leishmania braziliensis: synthesis, biological evaluation, molecular modeling and structure-activity relationship (SAR).
Topics: Antiprotozoal Agents; Chalcone; Leishmania braziliensis; Models, Molecular; Structure-Activity Relationship | 2011 |
Synthesis and antikinetoplastid activity of a series of N,N'-substituted diamines.
Topics: Animals; Antiprotozoal Agents; Chagas Disease; Diamines; Humans; Inhibitory Concentration 50; Kinetoplastida; Leishmaniasis, Visceral; Molecular Structure; Small Molecule Libraries; Trypanosomiasis, African | 2012 |
Amino acid, dipeptide and pseudodipeptide conjugates of ring-substituted 8-aminoquinolines: synthesis and evaluation of anti-infective, β-haematin inhibition and cytotoxic activities.
Topics: Amino Acids; Aminoquinolines; Animals; Anti-Infective Agents; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Dipeptides; Fungi; Hemeproteins; Leishmania donovani; Mice; Peptidomimetics; Plasmodium falciparum; Vero Cells | 2012 |
Antiprotozoal and antimicrobial compounds from the plant pathogen Septoria pistaciarum.
Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Ascomycota; Aspergillus fumigatus; Candida albicans; Candida glabrata; Chlorocebus aethiops; Chloroquine; Cryptococcus neoformans; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium avium Complex; Plasmodium falciparum; Pseudomonas aeruginosa; Staphylococcus aureus; Vero Cells | 2012 |
Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Topics: Animals; Antiprotozoal Agents; Drug Discovery; Hep G2 Cells; Humans; Leishmania donovani; Life Cycle Stages; Mice; Nitroquinolines | 2012 |
Flavonoid dimers as novel, potent antileishmanial agents.
Topics: Amines; Animals; Antiprotozoal Agents; Cell Line; Dimerization; Drug Resistance; Flavonoids; Leishmania; Macrophages, Peritoneal; Mice; Polyethylene Glycols; Structure-Activity Relationship | 2012 |
Antimicrobial and antiprotozoal activities of secondary metabolites from the fungus Eurotium repens.
Topics: | 2012 |
Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.
Topics: Antiprotozoal Agents; Drug Discovery; Humans; Indoles; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis, Visceral; Models, Chemical; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation against Leishmania amazonensis of a series of alkyl-substituted benzophenones.
Topics: Amphotericin B; Animals; Benzophenones; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Leishmania mexicana; Life Cycle Stages; Macrophages, Peritoneal; Mice; Structure-Activity Relationship; Trypanocidal Agents | 2013 |
Synthesis of novel guttiferone A derivatives: in-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovani.
Topics: Antiprotozoal Agents; Benzophenones; Clusiaceae; Dose-Response Relationship, Drug; Leishmania donovani; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Seeds; Structure-Activity Relationship; Trypanosoma brucei brucei | 2013 |
Synthesis and antiprotozoal activity of dicationic m-terphenyl and 1,3-dipyridylbenzene derivatives.
Topics: Animals; Antiprotozoal Agents; Benzene; Chagas Disease; Female; Leishmania donovani; Mice; Mice, Inbred Strains; Models, Chemical; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyridines; Structure-Activity Relationship; Terphenyl Compounds; Trypanosoma cruzi | 2013 |
Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series.
Topics: Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Imidazoles; Leishmania donovani; Mice; Pyridines; Structure-Activity Relationship | 2013 |
Mycoleptones A-C and polyketides from the endophyte Mycoleptodiscus indicus.
Topics: Benzofurans; Brazil; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Endophytes; HL-60 Cells; Humans; Leishmania; Lymphocytes; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Polyketides; Rubiaceae | 2014 |
Synthesis and antiparasitic activity of new bis-arylimidamides: DB766 analogs modified in the terminal groups.
Topics: Amides; Animals; Antiparasitic Agents; Cell Line; Chemistry Techniques, Synthetic; Leishmania; Plasmodium falciparum; Rats; Trypanosoma | 2014 |
Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
Topics: Animals; Antiprotozoal Agents; Carbolines; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Leishmania donovani; Macrophages; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Swine; Trypanosoma brucei brucei; Vero Cells | 2014 |
Antileishmanial metabolites from Geosmithia langdonii.
Topics: Antineoplastic Agents, Phytogenic; Aspergillus fumigatus; Benzhydryl Compounds; Candida; Cyclohexanones; Escherichia coli; Hypocreales; Leishmania donovani; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium avium Complex; Plasmodium falciparum; Pseudomonas aeruginosa; Salicylates | 2014 |
The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Histone Deacetylase Inhibitors; Histone Deacetylases; Isoenzymes; Leishmania donovani; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship | 2014 |
Thymol and eugenol derivatives as potential antileishmanial agents.
Topics: Animals; Antiprotozoal Agents; Cell Line; Eugenol; Humans; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Male; Mice; Mice, Inbred BALB C; Thymol | 2014 |
New series of monoamidoxime derivatives displaying versatile antiparasitic activity.
Topics: Antiparasitic Agents; Carbon-13 Magnetic Resonance Spectroscopy; Inhibitory Concentration 50; Oximes; Spectrometry, Mass, Electrospray Ionization | 2014 |
Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Leishmania donovani; Molecular Structure; Nitroquinolines; Parasitic Sensitivity Tests; Structure-Activity Relationship | 2015 |
Antivascular and anti-parasite activities of natural and hemisynthetic flavonoids from New Caledonian Gardenia species (Rubiaceae).
Topics: Angiogenesis Inhibitors; Animals; Antiparasitic Agents; Cell Line, Tumor; Cell Survival; Drug Design; Flavonoids; Flowers; Gardenia; Humans; Leishmania; Molecular Structure; New Caledonia; Plant Extracts; Plasmodium falciparum; Structure-Activity Relationship; Trypanosoma brucei gambiense | 2015 |
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
Topics: Antiprotozoal Agents; Drug Design; Hep G2 Cells; Humans; Leishmania donovani; Leishmania infantum; Life Cycle Stages; Macrophages; Nitroquinolines; Parasitic Sensitivity Tests; Pentamidine; Phosphorylcholine; Structure-Activity Relationship | 2015 |
Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
Topics: Chalcone; Inhibitory Concentration 50; Leishmania infantum; Prenylation; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
Topics: Animals; Dose-Response Relationship, Drug; Leishmania; Macrophages; Mice; Molecular Structure; Parasitic Sensitivity Tests; Phosphorylcholine; Structure-Activity Relationship; Triazoles; Trypanocidal Agents | 2015 |
Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; DNA-Binding Proteins; Furans; Humans | 2015 |
Synthesis and biological evaluation of polyalthic acid derivatives for the treatment of neglected diseases.
Topics: Antiparasitic Agents; Diterpenes; Inhibitory Concentration 50; Leishmania donovani; Molecular Structure; Neglected Diseases; Trypanocidal Agents; Trypanosoma brucei brucei | 2015 |
Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors.
Topics: Alkyl and Aryl Transferases; Animals; Antiparasitic Agents; Cell Line; Enzyme Inhibitors; Humans; Imidazoles; Leishmania donovani; Leishmaniasis, Visceral; Malaria, Falciparum; Mice; Parasitic Sensitivity Tests; Plasmodium falciparum; Trypanosoma; Trypanosoma brucei brucei; Trypanosoma cruzi; Trypanosomiasis | 2016 |
Antitrypanosomal and antileishmanial activity of prenyl-1,2,3-triazoles.
Topics: | 2017 |
Bioactive products from singlet oxygen photooxygenation of cannabinoids.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Bacteria; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fungi; Humans; Leishmania major; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Photochemical Processes; Plasmodium falciparum; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Singlet Oxygen | 2018 |
Synthesis and leishmanicidal activity of eugenol derivatives bearing 1,2,3-triazole functionalities.
Topics: Animals; Antiprotozoal Agents; Cell Survival; Dose-Response Relationship, Drug; Eugenol; Leishmania; Macrophages; Mice; Mice, Inbred BALB C; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Triazoles | 2018 |
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections.
Topics: Antiprotozoal Agents; Chagas Disease; Dose-Response Relationship, Drug; Humans; Macrophages; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Thiosemicarbazones; Trypanosoma | 2018 |
Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Leishmania donovani; Molecular Structure; Parasitic Sensitivity Tests; Quinoxalines; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosoma cruzi | 2018 |
New series of 3,5-disubstituted tetrahydro-2H-1,3,5-thiadiazine thione (THTT) derivatives: Synthesis and potent antileishmanial activity.
Topics: 3T3 Cells; Animals; Antiprotozoal Agents; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Leishmania major; Magnetic Resonance Spectroscopy; Mice; Prodrugs; Structure-Activity Relationship; Thiones | 2018 |
Antileishmanial Carbasugars from Geosmithia langdonii.
Topics: Animals; Antiparasitic Agents; Carbasugars; Circular Dichroism; Hypocreales; Leishmania donovani; Magnetic Resonance Spectroscopy; Molecular Structure; Sugars | 2018 |
Nongenotoxic 3-Nitroimidazo[1,2-
Topics: | 2019 |
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
Topics: Animals; Antiprotozoal Agents; Benzothiazoles; Binding Sites; Catalytic Domain; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Half-Life; Leishmania major; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Oxidoreductases; Protozoan Proteins; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosomiasis | 2019 |
N, N', N″-trisubstituted guanidines: Synthesis, characterization and evaluation of their leishmanicidal activity.
Topics: Animals; Antiprotozoal Agents; Dose-Response Relationship, Drug; Female; Guanidines; Leishmania; Leishmaniasis; Mice; Mice, Inbred BALB C; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship | 2019 |
Synthesis and antileishmanial evaluation of thiazole orange analogs.
Topics: Animals; Benzothiazoles; Drug Discovery; Leishmaniasis, Visceral; Quinolines | 2020 |
Expanding the scope of synthetic 1,2,4-trioxanes towards Trypanosoma cruzi and Leishmania donovani.
Topics: Antiparasitic Agents; Dose-Response Relationship, Drug; Heterocyclic Compounds; Leishmania donovani; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanosoma cruzi | 2020 |
Exploring the chemical space of 1,2,3-triazolyl triclosan analogs for discovery of new antileishmanial chemotherapeutic agents.
Topics: | 2021 |
Cutaneous leishmaniasis.
Topics: Amphotericin B; Antimony; Humans; Leishmania; Leishmaniasis; Pentamidine; Skin | 1976 |
Antileishmanial activity of hamycin: a polyene antibiotic.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Deoxyglucose; Ergosterol; Glucose; Humans; Kinetics; Leishmania donovani; Oxygen Consumption; Pentamidine; Polyenes | 1992 |
Visceral leishmaniasis in HIV-infected patients.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Spain; Treatment Outcome | 1991 |
Experimental studies on the nephrotoxicity of pentamidine in rats.
Topics: Amphotericin B; Animals; Cyclosporins; Female; Fosfomycin; Kidney; Pentamidine; Rats; Rats, Inbred Strains | 1991 |
Infectious disease emergencies in persons with HIV/AIDS: an update.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Clindamycin; Communicable Diseases; Fluconazole; HIV Infections; Humans; Opportunistic Infections; Pentamidine; Pyrimethamine; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Acute, rapidly progressive renal failure with simultaneous use of amphotericin B and pentamidine.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Amphotericin B; Drug Therapy, Combination; Female; Humans; Male; Mycoses; Pentamidine; Pneumonia, Pneumocystis | 1990 |
Semiautomated assessment of in vitro activity of potential antileishmanial drugs.
Topics: Aminoquinolines; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Automation; Azure Stains; Drug Evaluation, Preclinical; Formycins; Humans; In Vitro Techniques; Ketoconazole; Leishmania tropica; Macrophages; Pentamidine; Tritium; Uracil | 1985 |
Antimicrobial susceptibility of Pneumocystis carinii in culture.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Cell Line; Chloroquine; Culture Media; Drug Combinations; Humans; Metronidazole; Miconazole; Pentamidine; Pneumocystis; Rats; Rats, Inbred Strains; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
An in vitro model for investigation of chemotherapeutic agents in leishmaniasis.
Topics: Amidines; Amphotericin B; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Macrophages; Pentamidine | 1980 |
In vitro susceptibility of antimony-resistant Leishmania to alternative drugs.
Topics: Amphotericin B; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antimony; Formycins; Humans; Imidazoles; Ketoconazole; Leishmaniasis; Pentamidine; Piperazines | 1982 |
Fine-structural alterations in Leishmania tropica within human macrophages exposed to antileishmanial drugs in vitro.
Topics: Aminoquinolines; Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Membrane; Formycins; Humans; Intracellular Membranes; Ketoconazole; Leishmania; Macrophages; Organoids; Pentamidine | 1983 |
An evolution of therapy for mucocutaneous candidiasis.
Topics: Amphotericin B; Antifungal Agents; Benzalkonium Compounds; Candida; Candidiasis; Candidiasis, Cutaneous; Child; Child, Preschool; Chronic Disease; Female; Gentian Violet; Humans; Infant; Infant, Newborn; Male; Mucous Membrane; Pentamidine; Skin | 1980 |
Drug cytotoxicity assay for African trypanosomes and Leishmania species.
Topics: Acid Phosphatase; Amphotericin B; Animals; Camptothecin; Diminazene; Drug Evaluation, Preclinical; Leishmania donovani; Pentamidine; Trypanocidal Agents; Trypanosoma brucei brucei | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Substance Abuse, Intravenous | 1994 |
Development and characterization of a rapid screening assay for identifying antipneumocystis agents.
Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Atovaquone; Cell Membrane Permeability; Fungal Proteins; Membrane Glycoproteins; Methionine; Microbial Sensitivity Tests; Naphthoquinones; Pentamidine; Pneumocystis; Precipitin Tests; Sulfur Radioisotopes; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha | 1993 |
Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine.
Topics: Amphotericin B; Animals; Disease Models, Animal; Female; Immunocompromised Host; Immunosuppression Therapy; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Mice, Nude; Pentamidine; T-Lymphocytes | 1993 |
Treatment of visceral leishmaniasis unresponsive to pentamidine with amphotericin B.
Topics: Amphotericin B; Anti-Bacterial Agents; Antiprotozoal Agents; Drug Administration Schedule; Humans; Leishmaniasis, Visceral; Pentamidine | 1995 |
Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in humans and other animals.
Topics: Amebiasis; Amoeba; Amphotericin B; Animals; Antiprotozoal Agents; Benzamidines; Cell-Free System; Culture Media; Drug Resistance; Humans; Meningoencephalitis; Microbial Sensitivity Tests; Opportunistic Infections; Pentamidine | 1996 |
Rhinocerebral mucormycosis in a patient with AIDS: a complication of diabetic ketoacidosis following pentamidine therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Biopsy; Brain; CD4 Lymphocyte Count; Diabetes Complications; Humans; Male; Mucormycosis; Nasopharynx; Pentamidine; Pneumonia, Pneumocystis | 1996 |
Amphotericin B in visceral leishmaniasis.
Topics: Amphotericin B; Anti-Bacterial Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance, Microbial; Humans; Leishmaniasis, Visceral; Pentamidine | 1996 |
Leishmania infantum promastigotes: flow cytometry as a possible tool for assessing the effects of drugs on cellular functions.
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Carbocyanines; Cell Cycle; Coloring Agents; DNA, Protozoan; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Leishmania infantum; Membrane Potentials; Pentamidine; Phenylmercury Compounds; Propidium; Protozoan Proteins; Sulfhydryl Compounds; Sulfhydryl Reagents | 1997 |
[Evaluation of effective treatment drugs against Acanthamoeba cyst].
Topics: Acanthamoeba; Amphotericin B; Animals; Anti-Infective Agents, Local; Antifungal Agents; Antiprotozoal Agents; Cornea; Fluconazole; Humans; Keratitis; Miconazole; Natamycin; Pentamidine | 1997 |
Visceral leishmaniasis in patients infected with the human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Allopurinol; Amebicides; Amphotericin B; Analysis of Variance; Anti-HIV Agents; Antimetabolites; Antimony; Antiprotozoal Agents; Blood; Bone Marrow; CD4-Positive T-Lymphocytes; Cerebrospinal Fluid; Didanosine; Digestive System; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatic Encephalopathy; HIV; Humans; Intestinal Mucosa; Leishmaniasis, Visceral; Lymphocyte Count; Male; Myocarditis; Neutrophils; Pancreatitis; Pentamidine; Renal Insufficiency; Spain; Zidovudine | 1997 |
Synergistic effect of Ir-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Synergism; Female; Iridium; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Organometallic Compounds; Paromomycin; Pentamidine; Random Allocation | 1998 |
Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum.
Topics: Amphotericin B; Animals; Antimony Potassium Tartrate; Antiprotozoal Agents; Cell Line; Drug Resistance; Humans; Leishmania infantum; Meglumine; Meglumine Antimoniate; Mutation; Organometallic Compounds; Pentamidine | 2000 |
Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
Topics: Adolescent; Adult; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Equipment Contamination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Hepatitis C Antibodies; HIV Antibodies; HIV Infections; Humans; India; Injections, Intramuscular; Leishmaniasis, Visceral; Male; Needles; Pentamidine; Prevalence; Social Class | 2000 |
Drug resistance in Indian visceral leishmaniasis.
Topics: Aminoquinolines; Amphotericin B; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Resistance; Geography; History, 20th Century; History, 21st Century; Humans; India; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine; Treatment Outcome | 2001 |
In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.
Topics: Amphotericin B; Antifungal Agents; Drug Synergism; Humans; Microbial Sensitivity Tests; Models, Biological; Pentamidine; Scedosporium | 2002 |
Balamuthia mandrillaris from soil samples.
Topics: Amphotericin B; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Azithromycin; DNA, Mitochondrial; DNA, Protozoan; DNA, Ribosomal; Fluconazole; Flucytosine; Fluorescent Antibody Technique, Indirect; Genes, rRNA; Lobosea; Microscopy; Molecular Sequence Data; Parasitic Sensitivity Tests; Pentamidine; Phylogeny; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Soil; Sulfadiazine | 2004 |
Challenges in the management of visceral leishmaniasis.
Topics: Amebicides; Amphotericin B; Antimony Sodium Gluconate; Antiparasitic Agents; Antiprotozoal Agents; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Humans; Immunoglobulin G; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine | 2005 |
Antileishmanial activity of polycyclic derivatives.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Humans; Leishmania; Pentamidine; Polycyclic Compounds; Quantitative Structure-Activity Relationship | 2005 |
Development of a semi-automated colorimetric assay for screening anti-leishmanial agents.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Colorimetry; Drug Evaluation, Preclinical; Humans; Indicators and Reagents; Inhibitory Concentration 50; Kinetics; Leishmania; Leishmania donovani; Leishmaniasis, Visceral; Pentamidine; Phosphorylcholine; Tetrazolium Salts; Thiazoles | 2006 |
An HIV-positive man with tattoo induration.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immunohistochemistry; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Risk Assessment; Tattooing | 2007 |
Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine a
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Drug Carriers; HIV Infections; Humans; Leishmaniasis, Visceral; Liposomes; Male; Paromomycin; Pentamidine; Treatment Failure | 2008 |
The Mediterranean red alga Asparagopsis: a source of compounds against Leishmania.
Topics: Amphotericin B; Inhibitory Concentration 50; Italy; Leishmania; Leishmaniasis; Mediterranean Sea; Pentamidine; Rhodophyta; Trypanocidal Agents | 2009 |
In vitro activity of nicotinamide/antileishmanial drug combinations.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Cell Line; DNA Fragmentation; Drug Combinations; Drug Resistance; Flow Cytometry; Humans; Leishmania infantum; Leishmaniasis; Niacinamide; Parasitic Sensitivity Tests; Pentamidine | 2011 |
Trypanosoma lewisi or T. lewisi-like infection in a 37-day-old Indian infant.
Topics: Amphotericin B; Anti-Bacterial Agents; Antiprotozoal Agents; Ceftriaxone; Humans; Infant; Male; Pentamidine; Trypanosoma lewisi; Trypanosomiasis | 2011 |
Investigation into in vitro anti-leishmanial combinations of calcium channel blockers and current anti-leishmanial drugs.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Calcium Channel Blockers; Cricetinae; Drug Therapy, Combination; Leishmania; Leishmaniasis, Visceral; Macrophages, Peritoneal; Mesocricetus; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Pentamidine | 2011 |
Preparation and antiprotozoal evaluation of promising β-carboline alkaloids.
Topics: Alkaloids; Amphotericin B; Antiprotozoal Agents; Carbolines; Chloroquine; Doxycycline; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; Leishmania donovani; Pentamidine; Plasmodium falciparum; Structure-Activity Relationship | 2012 |
The influence of treatment on the development of leishmaniasis recidiva cutis: a 17-year case-control study in Midwestern Brazil.
Topics: Adolescent; Adult; Amphotericin B; Brazil; Case-Control Studies; Female; Humans; Incidence; Leishmaniasis, Cutaneous; Longitudinal Studies; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Trypanocidal Agents; Young Adult | 2015 |
Leishmanicidal activities of novel synthetic furoxan and benzofuroxan derivatives.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Benzoxazoles; Hydrogen-Ion Concentration; Leishmania mexicana; Life Cycle Stages; Macrophages; Male; Mice; Nitric Oxide; Nitrites; Oxadiazoles; Parasitic Sensitivity Tests; Pentamidine; Structure-Activity Relationship | 2014 |
Visceral leishmaniasis complicating idiopathic CD4+ T-cell lymphocytopenia: 2 case reports.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Pentamidine; T-Lymphocytopenia, Idiopathic CD4-Positive | 2017 |
A defined medium for Leishmania culture allows definition of essential amino acids.
Topics: Amino Acids, Essential; Amphotericin B; Animals; Antiprotozoal Agents; Culture Media; Inhibitory Concentration 50; Leishmania; Leishmania donovani; Leishmania major; Leishmania mexicana; Methotrexate; Pentamidine; Serial Passage; Species Specificity | 2018 |
Design, Synthesis and Biological Evaluation of 7-arylbenzo[c]acridine-5,6- diones as Potential Anti-Leishmanial and anti-trypanosomal Agents.
Topics: Acridines; Amphotericin B; Animals; Chlorocebus aethiops; Doxorubicin; Drug Design; Eflornithine; Hep G2 Cells; Humans; Leishmania donovani; Parasitic Sensitivity Tests; Pentamidine; Swine; Trypanocidal Agents; Trypanosoma brucei brucei; Vero Cells | 2018 |
Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Amphotericin B; Antimony; Antiprotozoal Agents; Brazil; Cohort Studies; Deoxycholic Acid; Drug Combinations; Female; Humans; Itraconazole; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Liposomes; Male; Middle Aged; Pentamidine; Retrospective Studies; Treatment Outcome | 2019 |
Case Report: Combination Therapy with Liposomal Amphotericin B, N-Methyl Meglumine Antimoniate, and Pentamidine Isethionate for Disseminated Visceral Leishmaniasis in a Splenectomized Adult Patient.
Topics: Amphotericin B; Antiprotozoal Agents; Bone Marrow; Drug Therapy, Combination; Humans; Immunocompromised Host; Intestinal Mucosa; Leishmaniasis, Visceral; Lymph Nodes; Male; Meglumine Antimoniate; Middle Aged; Pentamidine; Splenectomy | 2020 |
Antileishmanial drugs activate inflammatory signaling pathways via toll-like receptors (docking approach) from Leishmania amazonensis-infected macrophages.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Inflammation; Leishmania; Leishmaniasis; Macrophages; Meglumine Antimoniate; Mice; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; Pentamidine; Signal Transduction; Toll-Like Receptors; Transcription Factor RelA | 2020 |
Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
Topics: Administration, Intravenous; Aged; Amphotericin B; Antiprotozoal Agents; Argentina; Azoles; Drug Therapy, Combination; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Pentamidine; Recurrence | 2020 |
Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of
Topics: Amphotericin B; Combined Modality Therapy; Humans; Leishmaniasis, Cutaneous; Pentamidine; Skin | 2023 |